AIM IMMUNOTECH INC. Payments for Commissions
AIM IMMUNOTECH INC. (AIM) reported Payments for Commissions of $25.00 thousand for the 0-month period ending 2018-03-24, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForCommissions · last filed 2020-03-30
- 2018-03-24: Payments for Commissions 0 month $25.00K.
| Period end | Payments for Commissions 0 month |
|---|---|
| 2018-03-24 | $25.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |